Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
|Title||Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.|
|Publication Type||Journal Article|
|Year of Publication||2006|
|Authors||Ercoli, L, Siddarth P, Huang S-C, Miller K, Bookheimer SY, Wright BC, Phelps ME, Small G|
|Journal||Archives of general psychiatry|
|Date Published||2006 Apr|
|Keywords||Aged, Aged, 80 and over, Alzheimer Disease, Apolipoprotein E4, Apolipoproteins E, Awareness, Brain, Cognition Disorders, Fluorodeoxyglucose F18, Functional Laterality, Genetic Predisposition to Disease, Genotype, Glucose, Health Status, Heterozygote, Humans, Longitudinal Studies, Memory Disorders, Middle Aged, Neuropsychological Tests, Positron-Emission Tomography, Questionnaires|
Concerns about age-related memory loss are greater in persons who have the apolipoprotein E-IV (APOE4) genetic risk for Alzheimer disease, but the correlation between the degree of concerns and future cerebral metabolic decline is unknown.
|Alternate Journal||Arch. Gen. Psychiatry|